Advanced Life Sciences to Be Featured at 2002
Illinois Venture Capital Conference
Woodridge, Ill, September 25, 2002 - Advanced Life Sciences,
Inc. (ALS) will be one of the elite high-growth Mid-American companies
showcased at the 2002 Illinois Venture Capital Conference to be
held tomorrow at the Chicago Marriott. The conference sponsors
selected 17 companies, including ALS, for presentation that already
have seed capital, a developed product and quality management.
Michael T. Flavin, Ph.D., ALS's chief executive officer will outline
ALS's technology, products and business plans to an audience of
more than 500 investors and institutional venture capitalists.
Advanced Life Sciences is a privately held biopharmaceutical company
engaged in the discovery, development and commercialization of
novel drugs in the therapeutic areas of infection, cancer, and
inflammation using its platform in natural products and chemical
proteomics coupled with expertise in drug development. (www.advancedlifesciences.com)